Concord Drugs Ltd. Live Share Price Today, Share Analysis and Chart

Name: Concord Drugs Ltd.: Is Infosys Ltd. worth buying?
Item: Concord Drugs Ltd.
Rating: 2.749208375
Author: Trendlyne DVM scores

Turnaround Potential

about

64.60 -1.31 (-1.99%)

16,639

BSE Volume

BSE 15 Jul, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Mid Valuation

44.7 / 100

Technically Bullish

75.3 / 100

Concord Drugs Live Price Chart

Loading Fundamental data..

Loading data..

12 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%